NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The FOI reply is therefore not a casual acknowledgment that the MHRA possesses meeting summaries. It is a formal confirmation that they hold the exact information requested, that a CHM discussion took place in May or June 2025 on a brain cancer medicine, and that it will be made public in the CHM summary minutes when the formal publication process is complete.

May be it was discussed then, but the FOI reply does not establish that.

The question asked was :

I would greatly appreciate it if you could confirm whether any discussions during the most recent May 2025 or June 2025 CHM meetings involved a medicine for the treatment of brain cancer.

The meeting summary will answer Lykiri's question even if it was not discussed.